Deferasirox vs deferoxamine
Responder analysis II (responder: LIC 1 to less than 7 mg Fe/g dw) · people with transfusion‐dependent thalassemia
Deferasirox probably leads to lower responder analysis II (responder: LIC 1 to less than 7 mg Fe/g dw) compared with deferoxamine (moderate certainty).
1 finding from 1 review
- Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes onlyRR 0.8 [0.69, 0.92]1 study · 553 participantsModerate